Thyroid Carcinoma Clinical Trials

11 recruiting

Thyroid Carcinoma Trials at a Glance

25 actively recruiting trials for thyroid carcinoma are listed on ClinicalTrialsFinder across 6 cities in 7 countries. The largest study group is Not Applicable with 7 trials, with the heaviest enrollment activity in Guangzhou, Houston, and Beijing. Lead sponsors running thyroid carcinoma studies include Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, M.D. Anderson Cancer Center, and IRCCS Azienda Ospedaliero-Universitaria di Bologna.

Browse thyroid carcinoma trials by phase

Treatments under study

About Thyroid Carcinoma Clinical Trials

Looking for clinical trials for Thyroid Carcinoma? There are currently 11 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Thyroid Carcinoma trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Thyroid Carcinoma clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 25 trials

Recruiting
Not Applicable

Nanosecond Pulsed Field Ablation in the Management of T1N0M0 Papillary Thyroid Carcinoma

Thyroid Carcinoma
M.D. Anderson Cancer Center15 enrolled2 locationsNCT07218315
Recruiting
Phase 1Phase 2

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

Non-small Cell Lung CancerMetastatic Lung CancerMetastatic Lung Non-Small Cell Carcinoma+18 more
Institut de Recherches Internationales Servier554 enrolled11 locationsNCT05786924
Recruiting
Phase 1

Lesion Dosimetry With Iodine-124 in Metastatic Thyroid Carcinoma

Thyroid CarcinomaMetastatic Thyroid Carcinoma
Memorial Sloan Kettering Cancer Center60 enrolled1 locationNCT03647358
Recruiting
Not Applicable

Radiofrequency Ablation For Recurrent Parathyroid Carcinoma

Recurrent Parathyroid Carcinoma
M.D. Anderson Cancer Center20 enrolled1 locationNCT07475780
Recruiting
Phase 2

Agnostic Therapy in Rare Solid Tumors

Cancer of Unknown PrimarySoft Tissue SarcomaCholangiocarcinoma+38 more
Instituto do Cancer do Estado de São Paulo28 enrolled8 locationsNCT06638931
Recruiting

CEUS Improves the Diagnostic Performance of SRSS of Thyroid Carcinoma

Thyroid CarcinomaThyroid Nodule
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University800 enrolled1 locationNCT06146764
Recruiting

Thyroid Carcinoma in Cancer Patients Undergoing Radiotherapy

Thyroid CarcinomaPediatric Cancer
IRCCS Azienda Ospedaliero-Universitaria di Bologna2,550 enrolled2 locationsNCT07473518
Recruiting
Not Applicable

Sacituzumab Tirumotecan Combined With Immunotherapy in Advanced Thyroid Cancer

Poorly Differentiated Thyroid CarcinomaAdvanced Thyroid CarcinomaRadioiodine-refractory Differentiated Thyroid Cancer
Zhejiang Provincial People's Hospital94 enrolled1 locationNCT07068542
Recruiting
Early Phase 1

[177Lu]Lu-AKIR001 First-in-human Study

Thyroid Gland Anaplastic CarcinomaPoorly Differentiated Thyroid CarcinomaCancer Head and Neck+3 more
Karolinska University Hospital15 enrolled1 locationNCT06639191
Recruiting
Phase 3

CTR-FAPI-guided Precision Surgery for Newly Diagnosed MTC

Medullary Thyroid Carcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences150 enrolled1 locationNCT07383246
Recruiting

Laryngopharyngeal Injury After Endotracheal Intubation Under General Anesthesia

Gastric CancerCholangiocarcinomaPancreatic Carcinoma+3 more
Zhejiang University1,200 enrolled2 locationsNCT07359586
Recruiting
Not Applicable

Humanistic Continuing Care Via WeChat for Patients Undergoing Thermal Ablation of Papillary Thyroid Carcinoma

Papillary Thyroid Carcinoma
Ming-an Yu108 enrolled1 locationNCT07302672
Recruiting
Not Applicable

Comparative Study of Transaxillary Robotic Thyroidectomy With MRND Versus Conventional Open Surgery in N1b PTC

Lymphatic MetastasisPapillary Thyroid Carcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University876 enrolled1 locationNCT06623578
Recruiting
Phase 2

IMMUNORARE5: A National Platform of 5 Academic Phase II Trials Coordinated by Lyon University Hospital to Assess the Safety and the Efficacy of the IMMUNOtherapy With Domvanalimab + Zimberelimab Combination in Patients With Advanced RARE Cancers

Peritoneal MesotheliomaAnaplastic Thyroid CarcinomasCarcinoid Tumor+3 more
Hospices Civils de Lyon154 enrolled15 locationsNCT06790706
Recruiting
Phase 1

CD70-Targeted CAR-T Therapy in CD70-Positive Advanced Solid Tumors

Ovarian CancerCervical CancerLung Cancer+3 more
Chongqing Precision Biotech Co., Ltd90 enrolled1 locationNCT07181720
Recruiting
Not Applicable

Research on the Application of 68Ga-DOTA-CCK-FS PET/CT in MTC

Medullary Thyroid Carcinoma
Luo Yaping30 enrolled1 locationNCT07138716
Recruiting
Phase 2

Study of ST-1898 in Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Cancer

Differentiated Thyroid Carcinoma
Beijing Scitech-Mq Pharmaceuticals Limited60 enrolled1 locationNCT06359847
Recruiting

An International Study on Pediatric Patients With Rare Tumors.

MesotheliomaThyroid CarcinomaPleuropulmonary Blastoma+11 more
Azienda Ospedaliera di Padova6,250 enrolled1 locationNCT07072143
Recruiting

Evaluation of the Clinical Utility of Circulating Biomarkers in Advanced Thyroid Carcinomas

Thyroid Carcinoma
IRCCS Azienda Ospedaliero-Universitaria di Bologna10 enrolled1 locationNCT06863805
Recruiting

International PPB/DICER1 Registry

DICER1 SyndromeNeuroblastomaThyroid Carcinoma+16 more
Children's Hospitals and Clinics of Minnesota3,400 enrolled1 locationNCT03382158